26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

macrophage-activating factor (MAF) 473 macrophage chemotactic factors (MCFs)<br />

Secreted products of macrophages that have a protective effect on the body.<br />

Resting macrophage<br />

20 µm<br />

Macrophage.<br />

Activated macrophage<br />

Macrophage-histiocyte in bone marrow.<br />

and the ability to kill tumor cells. Macrophages are known<br />

by different names according to the tissue in which they are<br />

found such as the microglia of the central nervous system,<br />

Kupffer cells of the liver, alveolar macrophages of the lung,<br />

and osteoclasts in the bone.<br />

macrophage-activating factor (MAF)<br />

A lymphokine such as interferon-γ (IFN-γ) that accentuates<br />

the ability of macrophages to kill microbes and tumor cells;<br />

a lymphokine that enhances the phagocytic activity of a<br />

macrophage and bactericidal and tumoricidal properties.<br />

macrophage activation<br />

Multiple processes are involved in stimulation of macrophages<br />

including increases in size and number of<br />

cytoplasmic granules and a spread of membrane ruffling.<br />

Functional alterations include elevated metabolism and<br />

transport of amino acids and glucose, increased enzymatic<br />

activity, and an elevation in the number of prostaglandins,<br />

cyclic guanosine monophosphate (cGMP), plasminogen<br />

activator, intracellular calcium ions, phagocytosis, and<br />

pinocytosis and ability to lyse bacteria and tumor cells.<br />

macrophage chemotactic and activating factor<br />

(MCAF or MCP-1)<br />

A chemoattractant and activator of macrophages produced<br />

by fibroblasts, monocytes, and endothelial cells as a result of<br />

exogenous stimuli and endogenous cytokines such as tumor<br />

necrosis factor (TNF), interleukin-1 (IL1), and PDGF. It also<br />

has a role in activating monocytes to release an enzyme that<br />

is cytostatic for some tumor cells. MCAF also plays a role<br />

in endothelial leukocyte adhesion molecule 1 (ELAM-1)<br />

and CD11a and b surface expression in monocytes and is<br />

a potent degranulator of basophils. MCP-1 is a member of<br />

the chemokine β family and has a CC (cysteine–cysteine)<br />

amino acid sequence. It is chemotactic toward monocytes<br />

in vivo and in vitro, and activates monocytes. It shares 21%<br />

amino acid sequence homology with IL8. The 76-amino-acid<br />

mature form is derived from a 99-amino acid precursor. The<br />

MCP-1 receptor (CCR2A CCR2B) is a seven-transmembrane<br />

spanning G protein-coupled molecule of 39 kDa with<br />

homology to other cyokine receptors. Various normal and<br />

malignant cell types synthesize MCP-1, which can induce<br />

chemotaxis, enzyme release, and increased β 2-integrin cell<br />

adhesion molecule expression in monocytes and facilitate<br />

monocyte cytostatic activity against tumor cells activated by<br />

oxidized low density lipoprotein (LDL).<br />

macrophage chemotactic factors (MCFs)<br />

Cytokines that act with macrophages to facilitate migration.<br />

The group includes interleukins and interferons.<br />

COOH<br />

α<br />

COOH<br />

γ<br />

Macrophage colony-stimulating factor (M-CSF).<br />

M

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!